Skip Navigation LinksHome > May 2014 - Volume 22 - Issue 3 > Intrathecal and Intraventricular Vancomycin: A Literature Re...
Infectious Diseases in Clinical Practice:
doi: 10.1097/IPC.0000000000000107
Review Articles

Intrathecal and Intraventricular Vancomycin: A Literature Review

Wombwell, Eric PharmD, BCPS*†; Young, Nathaniel PharmD*

Collapse Box

Abstract

Guidelines for administration of vancomycin into the cerebrospinal fluid are not available, and dosing strategies are based off of case reports and small clinical trials, with most data published before 2005. The objective of this article was to review available literature on direct administration of vancomycin into the cerebrospinal fluid for treatment of central nervous system–related infections and to determine current best therapeutic practice in dosing vancomycin by intrathecal or intraventricular administration. Upon literature review, cited initial vancomycin doses ranged from 5 to 50 mg/d. Maintenance dosing strategies tended to fall between 5 and 10 mg/d to maintain goal trough levels of 5 to 15 µg/mL. Therapeutic monitoring was a consistent recommendation made by authors to maintain therapeutic levels as well as to avoid possible toxicities associated with intraventricular and intrathecal vancomycin administration. Toxicities were limited in review but included mental status changes and headaches.

Copyright © 2013 by Lippincott Williams & Wilkins

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.